Generic name: Cerebroprotein Hydrolysate
Strength: 60 mg/0.5 mL
Dosage form: Injectable solution
Pack: 1 pre-filled syringe
Route of administration: Intravenous (IV) or subcutaneous (SC)
Intramuscular administration: Not recommended / Do not administer IM
Prescription: Only prescribed by a consultant neurologist
Storage: Store below 15°C and protect from sunlight
What is Cerebrata Injection?
Cerebrata Injection contains cerebroprotein hydrolysate, a preparation consisting of low-molecular-weight peptides and amino acids derived from hydrolyzed brain proteins. It is used as a neurological medicine and is prescribed in selected neurological conditions under specialist medical supervision.
Because Cerebrata is administered by injection and is specifically prescribed by a consultant neurologist, treatment should be undertaken only according to the prescribing specialist’s instructions.
What is Cerebroprotein Hydrolysate Used For?
Cerebroprotein hydrolysate preparations have been used in the management of certain neurological conditions, particularly those involving cerebrovascular disease and neurological injury.
Depending on the clinical situation, cerebroprotein hydrolysate may be considered as part of treatment for conditions such as:
- Neurological consequences following stroke
- Traumatic brain injury
- Certain cognitive disorders
The decision to use Cerebrata depends on the patient’s diagnosis, clinical condition and treatment plan established by the consultant neurologist.
How Does Cerebroprotein Hydrolysate Work?
Cerebroprotein hydrolysate contains biologically active peptides and amino acids that have been investigated for their effects on neuronal function and survival.
Proposed mechanisms include supporting neuronal metabolism, influencing neurotrophic processes and helping protect nerve cells against certain forms of cellular stress.
Its use in clinical practice is therefore focused on neurological conditions where preservation or support of neuronal function may be clinically relevant.
How is Cerebrata Injection Administered?
Cerebrata 60 mg/0.5 mL is supplied as an injectable solution in a pre-filled syringe.
It may be administered by:
- Intravenous (IV) route
- Subcutaneous (SC) route
Cerebrata should NOT be administered intramuscularly (IM).
The dose, frequency and duration of treatment are determined by the prescribing consultant neurologist based on the patient’s condition and clinical requirements.
Patients should not attempt to administer Cerebrata themselves unless specifically instructed and appropriately trained by a healthcare professional.
Important Safety Information
Cerebrata is a specialist-prescribed injectable medicine. It should be used only under the supervision of the prescribing consultant neurologist.
Before treatment, the healthcare professional should be informed about:
- Existing medical conditions
- Allergies or previous reactions to medicines
- Current prescription medicines
- Over-the-counter medicines
- Vitamins and supplements
- Previous neurological conditions or treatments
Any unusual or severe reaction following administration should be reported promptly to the treating healthcare professional.
Storage and Handling
Cerebrata should be:
- Stored below 15°C
- Protected from sunlight
- Kept out of the reach of children
The product should remain in its appropriate packaging and should be handled according to the manufacturer’s instructions.
Do not use the medicine if the packaging or pre-filled syringe appears damaged or if there are visible abnormalities in the solution.
Who Should Prescribe Cerebrata?
Cerebrata should be prescribed by a consultant neurologist.
Because neurological disorders can have very different causes and treatment requirements, the decision to use cerebroprotein hydrolysate should be based on a specialist assessment rather than self-diagnosis.
Medicine Library Note
This information is provided for educational and medicine-information purposes. It does not replace the prescribing information supplied with the product or the advice of a qualified healthcare professional. Cerebrata should be used only when prescribed by the treating consultant neurologist.